Bionics Institute welcomes Dr Sherryl Wagstaff to Board
13 August 2020 Dr Sherryl Wagstaff (MBBS, FRACS MBA (MBS) GAICD), an ear-nose-and-throat (ENT) specialist and Medical Director at Epworth Eastern Hospital recently joined the Board of the Bionics Institute. Dr Wagstaff has been working with the Bionics…
CSIRO sets sights on new ‘Team Australia’ missions program
13 August 2020 CSIRO, Australia’s national science agency, will work with the government, universities, industry and the community, on a new missions program to bolster Australia’s COVID-19 recovery and build long term resilience. The program of large scale,…
Independent publication strengthens case for Noxopharm’s Veyonda® as a safe and possibly life-prolonging treatment in late- stage prostate cancer
11 August 2020 Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) is pleased to announce the publication of the first manuscript of the LuPIN trial in the journal, European Urology Oncology. This journal is the first official publication…
Sienna Cancer Diagnostics Ltd (Sienna) becomes a wholly owned subsidiary of BARD1 Life Sciences Ltd
10 August 2020 Release date: 4 August 2020 Dear Valued Stakeholders, We are pleased to inform you that on 28 July 2020, Sienna Cancer Diagnostics Ltd (Sienna) became a wholly owned subsidiary of BARD1 Life Sciences Ltd (BARD1…
Atmo Biosciences wins $620K grant to advance commercialization of ingestible gas-sensing capsule to diagnose gut disorders
6 August 2020 Release date: 20 July 2020 Atmo Biosciences has been awarded a $620,000 Australian Government grant through the BioMedTech Horizons (BMTH) program. Delivered by MTPConnect and funded by the Medical Research Future Fund, the BMTH program supports the…
New head lice treatment approved for use in USA
6 August 2020 Release date: 3 August 2020 A new prescription head lice treatment, developed by University of Melbourne Associate Professor Vern Bowles, has been given Food and Drug Administration (FDA) approval, allowing it to be sold in…
Funding Injection To Advance DMTC Vaccine Development
6 August 2020 A novel Q Fever vaccine is progressing to pre-clinical trials following a $1.87 million investment from the Department of Health into DMTC’s national Medical Countermeasures (MCM) Initiative. DMTC will work with research and industry partners to manage…
POF recognised as a leading Trade Mark Prosecution firm
August 6, 2020 Philips Ormonde Fitzpatrick are very pleased to announce that we’ve been recognised as a leading Trade Mark Prosecution firm by Asia IP in their 2020 Trade Mark Survey. This achievement is a great reflection of…
CSIRO launches Australia’s first accredited face mask testing facility
6 August 2020 CSIRO, Australia’s national science agency, has launched the nation’s first accredited surgical face mask testing facility in Melbourne today, to help frontline health workers in the fight against COVID-19, while supporting Australian business. The new…
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
6 August 2020 Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID‑19 vaccine with and without Matrix‑M™ adjuvant…
New Grant to Support ARMI Research in Understanding Blindness in Newborns
6 August 2020 A grant funded by the Angior Family Foundation has been awarded to ARMI to study Leber Congenital Amaurosis (LCA), a group of inherited retinal diseases that are the most common cause of blindness in newborn…
Iron study combats anaemia with cutting-edge computer simulation
6 August 2020 A new iron intervention study has determined which of the world’s low-and-middle income countries would benefit from using iron-containing micronutrient powders to tackle childhood anaemia. Using advanced computer simulation techniques, the study’s findings include individual…
